CC BY-NC-ND 4.0 · J Lab Physicians 2018; 10(04): 414-419
DOI: 10.4103/JLP.JLP_55_18
Original Article

Characterization and antimicrobial susceptibility of coagulase-negative staphylococci isolated from clinical samples

Prapti Bora
Department of Microbiology, Government Medical College and Hospital, Chandigarh, India
,
Priya Datta
Department of Microbiology, Government Medical College and Hospital, Chandigarh, India
,
Varsha Gupta
Department of Microbiology, Government Medical College and Hospital, Chandigarh, India
,
Lipika Singhal
Department of Microbiology, Government Medical College and Hospital, Chandigarh, India
,
Jagdish Chander
Department of Microbiology, Government Medical College and Hospital, Chandigarh, India
› Author Affiliations
Financial support and sponsorship: Nil.

ABSTRACT

PURPOSE: This study has been done to speciate coagulase-negative staphylococci (CoNS) and also study their antibiotic susceptibility pattern isolated from clinical samples.

MATERIALS AND METHODS: A total of 120 consecutive CoNS were isolated from various clinical samples such as blood, pus, wound swab, drain fluid, tracheal aspirate, peritoneal fluid, and pleural fluid over a period of 6 months. CoNS were identified by characteristic growth on media such as Blood agar and MacConkey agar. Speciation and identification were done by a range of biochemical testing such as PYR broth hydrolysis, novobiocin resistance, polymyxin B sensitivity, and then by matrix-assisted laser desorption ionization-time of flight. Antibiotic susceptibility of the isolates was done by Kirby-Bauer disk diffusion method as per CLSI 2017 guidelines.

RESULTS: Among the 120 isolates, the most common species was Staphylococcus epidermidis (56.67%) followed by Staphylococcus haemolyticus (21.67%), Staphylococcus lugdunensis (11.67%), Staphylococcus caprae (5%), Staphylococcus cohnii (3.33%), and finally Staphylococcus vitulinus (1.67%). Good in vitro susceptibility was noted toward linezolid (100%), vancomycin (100%), teicoplanin (100%), and doxycycline (80.2%). The antibiotics to which resistance was seen were penicillin (96.5%), ciprofloxacin (57.1%), and oxacillin (45.5%). MR CoNS in our study ranged from 50% to 68.67%.

CONCLUSION: Antibiotic resistance in CoNS is increasing toward penicillin, ciprofloxacin, and oxacillin as found in our study. The antibiotics such as vancomycin, teicoplanin, linezolid, and doxycycline which showed good in vitro susceptibility, therefore, should be kept as reserve drugs and used judiciously.



Publication History

Received: 21 April 2018

Accepted: 14 August 2018

Article published online:
20 February 2020

© 2018.

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • REFERENCES

  • 1 Procop GW, Church DL, Hall GS, Janda WM, Koneman EW, Schreckenberger PC, et al. Koneman's Colour Atlas and Textbook of Diagnostic Microbiology. 7th ed. Philadelphia: Wotter's Kluwer Health; 2017.
  • 2 Borriello SP, Murray PR, Funke G. Topley & Wilson's Microbiology & Microbial Infections Bacteriology. 10th ed. London: Hodder Arnold; 2005.
  • 3 Tille PM. Bailey & Scott's Diagnostic Microbiology. 13th ed. Missouri: Elsevier; 2014.
  • 4 Singh S, Dhawan B, Kapil A, Kabra SK, Suri A, Sreenivas V, et al. Coagulase-negative staphylococci causing blood stream infection at an Indian tertiary care hospital: Prevalence, antimicrobial resistance and molecular characterisation. Indian J Med Microbiol 2016;34:500-5.
  • 5 Becker K, Heilmann C, Peters G. Coagulase-negative staphylococci. Clin Microbiol Rev 2014;27:870-926.
  • 6 Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol 2003;41:4740-4.
  • 7 Pal N, Sharma B, Sharma R, Vyas L. Detection of inducible clindamycin resistance among staphylococcal isolates from different clinical specimens in Western India. J Postgrad Med 2010;56:182-5.
  • 8 Gautam V, Sethuraman N, Kaur R, Sachdev S, Marwaha N, Ray P, et al. Changing epidemiology of coagulase-negative staphylococci in normal flora of skin. Indian J Med Microbiol 2017;35:277-8.
  • 9 Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Twentieth Informational Supplement. CLSI Document M100. Wayne, PA: CLSI; 2017.
  • 10 Asaad AM. Coagulase-negative staphylococci clinical isolates: Infectious or contaminant, that is the question. Int J Med Microbiol 2016;1:101.
  • 11 Usha MG, Shwetha DC, Vishwanath G. Speciation of coagulase negative staphylococcal isolates from clinically significant specimens and their antibiogram. Indian J Pathol Microbiol 2013;56:258-60.
  • 12 Sheikh AF, Mehdinejad M. Identification and determination of coagulase negative staphylococcal species and antimicrobial susceptibility pattern of isolates from clinical specimens. Afr J Microbiol Res 2012;6:1669-74.
  • 13 Asangi SY, Mariraj J, Sathyanarayan MS. Nagabhushan. Speciation of clinically significant coagulase negative staphylococci and their antibiotic resistant pattern in a tertiary care hospital. Int J Biol Med Res 2011;2:735-9.
  • 14 Singh L, Cariappa MP, Das NK. Drug sensitivity pattern of various Staphylococcus species isolated at a tertiary care hospital. Med J Armed Forces India 2016;72:S62-6.